132 related articles for article (PubMed ID: 33062370)
1. KRAS Mutation in Serous Borderline Tumor of the Testis: Report of a Case and Review of the Literature.
Bouri S; Noël JC; Catteau X; Al Hajj Obeid W; Svistakov I; Roumeguère T; D'Haene N; Rorive S
Case Rep Urol; 2020; 2020():5419707. PubMed ID: 33062370
[TBL] [Abstract][Full Text] [Related]
2. Ovarian-type epithelial tumours of the testis: immunohistochemical and molecular analysis of two serous borderline tumours of the testis.
Bürger T; Schildhaus HU; Inniger R; Hansen J; Mayer P; Schweyer S; Radzun HJ; Ströbel P; Bremmer F
Diagn Pathol; 2015 Jul; 10():118. PubMed ID: 26197800
[TBL] [Abstract][Full Text] [Related]
3. Serous borderline tumor of the paratestis: a report of seven cases.
McClure RF; Keeney GL; Sebo TJ; Cheville JC
Am J Surg Pathol; 2001 Mar; 25(3):373-8. PubMed ID: 11224608
[TBL] [Abstract][Full Text] [Related]
4. Serous Borderline Ovarian Epithelial Type Tumors of Testis in A Young Man with Only Mass Resection: A Case Report.
Rahimi M; Moradi Y; Khaleghimehr F
Iran J Pathol; 2023; 18(4):476-479. PubMed ID: 38024554
[TBL] [Abstract][Full Text] [Related]
5. Borderline serous papillary tumour of the testis: a case report and review of the literature.
Ibrahim AS; Li C; Al-Jafari MS
Anticancer Res; 2012 Nov; 32(11):5011-3. PubMed ID: 23155272
[TBL] [Abstract][Full Text] [Related]
6. Paratesticular müllerian-type papillary serous tumor in a child.
Cohen MC; Shawis R; Evans C
Pediatr Dev Pathol; 2009; 12(4):297-300. PubMed ID: 19348511
[TBL] [Abstract][Full Text] [Related]
7. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
8. The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report.
Mori R; Futamura M; Morimitsu K; Saigo C; Miyazaki T; Yoshida K
World J Surg Oncol; 2017 Jun; 15(1):117. PubMed ID: 28662703
[TBL] [Abstract][Full Text] [Related]
9. Seromucinous borderline tumor of the testis-A case report.
Scholz B; Beckert M; Mordstein V; Hohmann N; Walther R; Papadopoulos T
Hum Pathol; 2017 Feb; 60():188-191. PubMed ID: 27597522
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic analysis of ovarian and testicular Müllerian papillary serous tumors.
Carano KS; Soslow RA
Mod Pathol; 1997 May; 10(5):414-20. PubMed ID: 9160304
[TBL] [Abstract][Full Text] [Related]
11. Serous borderline tumor of the paratestis.
Maruyama H; Ohyama N; Hosokawa Y; Momose H; Yamada K; Tsutsumi M; Kuniyasu H; Enomoto Y; Uematsu K; Konishi Y
Pathol Int; 2008 May; 58(5):311-6. PubMed ID: 18429831
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
[TBL] [Abstract][Full Text] [Related]
13. Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report.
Kubo C; Nagata S; Fukuda T; Kano R; Tanaka T; Nakanishi K; Ohsawa M; Nakatsuka SI
Diagn Pathol; 2018 Jun; 13(1):43. PubMed ID: 29960592
[TBL] [Abstract][Full Text] [Related]
14. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
[TBL] [Abstract][Full Text] [Related]
15. Serous cystadenoma of the epididymis of common epithelial ovarian type: case report with an immunohistochemical study.
Klimis T; Vlahos P; Kokotas N
J BUON; 2006; 11(2):237-40. PubMed ID: 17318978
[TBL] [Abstract][Full Text] [Related]
16. Serous tumor of low malignant potential arising in inguinal endosalpingiosis: report of a case.
Carrick KS; Milvenan JS; Albores-Saavedra J
Int J Gynecol Pathol; 2003 Oct; 22(4):412-5. PubMed ID: 14501827
[TBL] [Abstract][Full Text] [Related]
17. High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature.
Hatano Y; Tamada M; Asano N; Hayasaki Y; Tomita H; Morishige KI; Hara A
Diagn Pathol; 2019 Jan; 14(1):4. PubMed ID: 30636633
[TBL] [Abstract][Full Text] [Related]
18. Paratesticular serous papillary carcinoma. A report of six cases.
Jones MA; Young RH; Srigley JR; Scully RE
Am J Surg Pathol; 1995 Dec; 19(12):1359-65. PubMed ID: 7503358
[TBL] [Abstract][Full Text] [Related]
19. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD
Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
[TBL] [Abstract][Full Text] [Related]
20. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
Taylor J; McCluggage WG
Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
